Cellulose Sulfate Gel (CAS 9032-43-3)
QUICK LINKS
Cellulose Sulfate Gel is a modified biopolymer that is used in materials science and bioengineering research due to its unique properties. This gel is particularly valuable in the study of controlled release systems, where it is investigated for its ability to encapsulate and gradually deliver substances, a process governed by its degree of sulfation and the resultant charge interactions. In tissue engineering, Cellulose Sulfate Gel′s biocompatibility and structural similarities to the extracellular matrix make it a subject for scaffold material research, aiming to support cell attachment and proliferation. Additionally, its rheological properties are explored in the development of bio-inks for 3D bioprinting, where the gel′s viscosity and stability are critical for the construction of complex biological structures. Environmental scientists also utilize this gel in studies related to water purification, examining its potential as an adsorbent for removing contaminants due to its high surface area and chemical functionality.
Cellulose Sulfate Gel (CAS 9032-43-3) References
- Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats. | Ghosh, R., et al. 2001. Contraception. 64: 261-9. PMID: 11747877
- Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL). | Barnhart, KT., et al. 2005. Contraception. 72: 65-70. PMID: 15964295
- Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel. | Malonza, IM., et al. 2005. AIDS. 19: 2157-63. PMID: 16284466
- Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. | El-Sadr, WM., et al. 2006. AIDS. 20: 1109-16. PMID: 16691061
- Noncomparative contraceptive efficacy of cellulose sulfate gel. | Mauck, CK., et al. 2008. Obstet Gynecol. 111: 739-46. PMID: 18310379
- Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. | Van Damme, L., et al. 2008. N Engl J Med. 359: 463-72. PMID: 18669425
- Ormeloxifene efficiently inhibits ovarian cancer growth. | Maher, DM., et al. 2015. Cancer Lett. 356: 606-12. PMID: 25306892
- Nanoparticle formulation of ormeloxifene for pancreatic cancer. | Khan, S., et al. 2015. Biomaterials. 53: 731-43. PMID: 25890768
- Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression. | Hafeez, BB., et al. 2017. Mol Cancer Ther. 16: 2267-2280. PMID: 28615299
- Selective estrogen receptor modulator ormeloxifene suppresses embryo implantation via inducing miR-140 and targeting insulin-like growth factor 1 receptor in rat uterus. | Sirohi, VK., et al. 2018. J Steroid Biochem Mol Biol. 178: 272-282. PMID: 29330027
- Ormeloxifene-induced unfolded protein response contributes to autophagy-associated apoptosis via disruption of Akt/mTOR and activation of JNK. | Bhattacharjee, A., et al. 2018. Sci Rep. 8: 2303. PMID: 29396506
- Evaluating the Effect of Ormeloxifene on Multiple Fibroadenomas and Mastalgia. | Brahmachari, S., et al. 2021. J Pharm Bioallied Sci. 13: S1386-S1389. PMID: 35017994
- Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia. | Verma, A., et al. 2022. Eur J Breast Health. 18: 248-251. PMID: 35855192
- Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension. | Abdulkareem, AO., et al. 2023. Eur J Pharmacol. 943: 175558. PMID: 36731722
- Ormeloxifene, a nonsteroidal antifertility drug promotes megakaryocyte differentiation in leukemia cell line K562. | Mishra, M., et al. 2023. Cell Biol Int.. PMID: 36950830
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cellulose Sulfate Gel, 10 g | sc-217868 | 10 g | $402.00 |